Frank Palantoni
CIK 1307963 · View on SEC EDGAR ↗
First SEC filing: Feb. 9, 2006 · Latest: Feb. 9, 2006
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2006 | PBH | P | 900 | $10.40 | $9,360 | 33,278 Direct | +2.78% | Acquired | 393.3% (price as of 2026-08-20) |
| May 19, 2006 | PBH | P | 1,490 | $10.38 | $15,466 | 32,378 Direct | +4.82% | Acquired | 394.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 21, 2023 | LXRX | Restricted Stock Units | Common Stock (9,302) | $0.00 | — | 9,302 | Disposed |
| April 28, 2023 | LXRX | Stock Option (Right to Buy) | Common Stock (12,658) | $2.36 | April 28, 2033 | 12,658 | Acquired |
| April 28, 2023 | LXRX | Restricted Stock Units | Common Stock (8,032) | $0.00 | — | 8,032 | Acquired |
| May 21, 2022 | LXRX | Restricted Stock Units | Common Stock (9,302) | $0.00 | — | 9,302 | Acquired |
| May 21, 2022 | LXRX | Stock Option (Right to Buy) | Common Stock (14,402) | $1.77 | May 21, 2032 | 14,402 | Acquired |
| April 30, 2022 | LXRX | Restricted Stock Units | Common Stock (4,024) | $0.00 | — | 4,024 | Disposed |
| April 30, 2021 | LXRX | Stock Option (Right to Buy) | Common Stock (6,475) | $5.04 | April 30, 2031 | 6,475 | Acquired |
| April 30, 2021 | LXRX | Restricted Stock Units | Common Stock (4,024) | $0.00 | — | 4,024 | Acquired |
| April 24, 2021 | LXRX | Restricted Stock Units | Common Stock (10,638) | $0.00 | — | 10,638 | Disposed |
| April 26, 2020 | LXRX | Restricted Stock Units | Common Stock (3,466) | — | — | 3,466 | Disposed |
| April 24, 2020 | LXRX | Restricted Stock Units | Common Stock (10,638) | $0.00 | — | 10,638 | Acquired |
| April 24, 2020 | LXRX | Stock Option (Right to Buy) | Common Stock (18,115) | $1.86 | April 24, 2030 | 18,115 | Acquired |
| April 26, 2019 | LXRX | Restricted Stock Units | Common Stock (3,466) | — | — | 3,466 | Acquired |
| April 26, 2019 | LXRX | Stock Option (Right to Buy) | Common Stock (6,519) | $5.67 | April 26, 2029 | 6,519 | Acquired |
| April 27, 2018 | LXRX | Stock Option (Right to Buy) | Common Stock (2,857) | $7.80 | April 27, 2028 | 2,857 | Acquired |
| April 28, 2017 | LXRX | Stock Option (Right to Buy) | Common Stock (2,857) | $15.61 | April 28, 2027 | 2,857 | Acquired |
| April 29, 2016 | LXRX | Stock Option (Right to Buy) | Common Stock (2,857) | $13.96 | April 29, 2026 | 2,857 | Acquired |
| April 24, 2015 | LXRX | Stock Option (Right to Buy) | Common Stock (20,000) | $1.07 | April 24, 2025 | 20,000 | Acquired |
| April 25, 2014 | LXRX | Stock Option (Right to Buy) | Common Stock (20,000) | $1.56 | April 25, 2024 | 20,000 | Acquired |
| May 10, 2013 | LXRX | Stock Option (Right to Buy) | Common Stock (20,000) | $1.98 | May 10, 2023 | 20,000 | Acquired |
| April 27, 2012 | LXRX | Stock Option (Right to Buy) | Common Stock (20,000) | $1.70 | April 27, 2022 | 20,000 | Acquired |
| March 26, 2012 | CENTA | Stock Option (Right to Buy) | Class A Common Stock (90,000) | $9.54 | March 26, 2018 | 90,000 | Acquired |
| April 29, 2011 | LXRX | Stock Option (Right to Buy) | Common Stock (10,000) | $1.69 | April 29, 2021 | 10,000 | Acquired |
| April 13, 2011 | CENTA | Stock Option (Right to Buy) | Class A Common Stock (100,000) | $9.26 | April 13, 2017 | 100,000 | Acquired |
| April 30, 2010 | LXRX | Stock Option (Right to Buy) | Common Stock (10,000) | $1.54 | April 30, 2020 | 10,000 | Acquired |
| April 24, 2009 | LXRX | Stock Option (right to buy) | Common Stock (10,000) | $0.99 | April 24, 2019 | 10,000 | Acquired |
| April 24, 2008 | LXRX | Stock Option (right to buy) | Common Stock (10,000) | $2.20 | April 24, 2018 | 10,000 | Acquired |
| April 26, 2007 | LXRX | Stock Option (right to buy) | Common Stock (10,000) | $3.77 | April 26, 2017 | 10,000 | Acquired |
| April 27, 2006 | LXRX | Stock Option (right to buy) | Common Stock (10,000) | $5.10 | April 27, 2016 | 10,000 | Acquired |
| Aug. 4, 2005 | PBH | Employee Stock Option (right to buy) | Common Stock, par value $0.01 per share (61,776) | $12.95 | Aug. 3, 2015 | 61,776 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 9, 2006 | PBH | Common Stock, par value $0.01 per share | 30,888 | Direct |
| Feb. 9, 2006 | PBH | Employee Stock Option (right to buy)→ Common Stock, par value $0.01 per share (61,776) | 61,776 | Direct |
| Nov. 4, 2004 | LXRX | Stock Option (right to buy)→ Common Stock (30,000) | 30,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CENTA
President and President – Pet Products(7)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | — | — | — | — | — | — | — | — |
PBH
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2007 | $113,760 | — | — | — | — | — | $581,600 | $695,360 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.